Substance / Medication

Moxifloxacin hydrochloride

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

22 trials linked to this intervention

22
Total Trials
4
Recruiting
6
With Results

Research Evidence

Published studies and systematic reviews

Sort:
In vitro antimicrobial analysis of aqueous humor after topical application of moxifloxacin hydrochloride 0.5%.
de Miranda Aline P, Silva Cely B, Mimica Lycia M J et al. · J Cataract Refract Surg · 2015
PMID: 25532640Observational
Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride.
Nanjwade Basavaraj K, Deshmukh Rucha V, Gaikwad Kishori R et al. · Eur J Drug Metab Pharmacokinet · 2012
PMID: 22015966Observational
Design and evaluation of moxifloxacin hydrochloride ocular inserts.
Pawar Pravin K, Katara Rajesh, Majumdar Dipak K · Acta Pharm · 2012
PMID: 22472452Observational
Enantiomeric purity assay of moxifloxacin hydrochloride by capillary electrophoresis.
Cruz Lou Ann, Hall Rex · J Pharm Biomed Anal · 2005
PMID: 15907612Observational
Development and in vitro-in vivo evaluation of ocular insert containing ketorolac tromethamine and moxifloxacin hydrochloride.
Koradia Krishna, Dedakia Arjun, Koradia Hiral · Ann Pharm Fr · 2025
PMID: 39413968Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Moxifloxacin hydrochloride (substance)
SNOMED CT
116347002
UMLS CUI
C0754517

Clinical Data

This intervention maps to 19 entities in the Healos knowledge graph.

19
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
22
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.